Go To MSN Labs
Novadoz Has a Fast Start to 2021 with Generic Launches of Albendazole, Droxidopa, Deferasirox Granules, and Pregabalin ER – Biospace.com
Dated On : April 23, 2021
FDA Approves Novadoz Pharmaceuticals Toremifene and Aminocaproic Acid, Bolstering their Continued Growth in Generics – Morningstar.com
Dated On : December 20, 2020
Novadoz gets FDA nod for generic Tamiflu, launches generic Tykosin – DrugStoreNews.com
Dated On : June 8, 2020
Novadoz Pharmaceuticals Increases Presence in the Generic Oncology Market with an FDA Approval of Thiotepa 15mg & 100mg Vials for Injection – ChicagoDailyHerald.com
Dated On : March 5, 2020
Novadoz Pharmaceuticals/MSN Labs is granted FDA Approval of generic Febuxostat Tablets, begins immediate shipping – BioSpace.com
Dated On : December 30, 2019
Novadoz Pharmaceuticals/MSN Labs Receives FDA Clearance for Fosaprepitant and Decitabine, The Company’s First Generic Specialty Products – Markets.BusinessInsider.com
Dated On : September 5, 2019
Novadoz Pharmaceuticals/MSN Labs gains FDA approval and commences shipping of Pregabalin capsules, the largest generic product launch of the year – TheStreet.com
Dated On : July 23, 2019
MSN Labs/Novadoz Pharmaceuticals Early Success Continues With FDA Approval of Generic Abiraterone – InternationalBusinessTimes.com
Dated On : July 15, 2019
MSN Labs/Novadoz Pharmaceuticals receives consecutive FDA approvals for their generic versions of Solifenacin and Trientine – Marketwatch.com
Dated On : May 28, 2019
Novadoz Receives Marketing Approval for Generic Versions of Rosuvastatin, Capecitabine, & Moxifloxacin – PRNewswire.com
Dated On : August 8, 2018